检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:周庆[1] 张东[2] 徐杰[1] 周丽[1] 李明阳[1]
机构地区:[1]解放军总医院南楼消化内镜诊疗科,北京100853 [2]解放军总医院南楼呼吸科,北京100853
出 处:《现代生物医学进展》2014年第1期123-125,共3页Progress in Modern Biomedicine
摘 要:目的:观察并分析奥美拉唑联合法莫替丁治疗反流性食管炎的临床效果。方法:选取2008年5月至2012年5月在本院确诊并治疗的反流性食管炎患者45例,随机平均分为三组。联合用药组(15例):每日早餐前口服20 mg奥美拉唑,睡前口服20 mg法莫替丁;奥美拉唑组(15例):每日口服两次奥美拉唑,每次20 mg;法莫替丁组(15例):每日口服两次法莫替丁,每次20 mg。每组的治疗时间均为8周。在内镜指导下观察并比较三组患者的胸痛、反酸和烧心等主要病征的改善情况,综合评价三种治疗方法的临床疗效。结果:联合用药组较其他两组获得的疗效更明显,患者的症状得到较好的改善,差异有统计学意义(P<0.05)。结论:奥美拉唑联合法莫替丁能够有效地抑制胃酸的分泌,对于反流性食管炎的临床治疗具有良好的效果。Objective: To observe and analyze the clinical effect of omeprazole combining with famotidine on the treatment of reflux esophagitis. Methods: 45 patients who were diagnosed and treated with reflux esophagitis in our hospital from May 2008 to May 2012 were randomly divided into three groups. Group A(15 cases): the patients were administrated oral drugs with omeprazole (20 mg) before breakfast and famotidine (20 mg) at bedtime; Group B (15 cases): the patients were administrated oral drugs with omeprazole (20 mg/once) twice a day; Group C (15 cases): the patients were administrated oral drugs with famotidine (20 mg/once) twice a day. The average time of the treatment was 8 weeks for the three groups. On the basis ofgastroscope, we comprehensively observed and analyzed the improved situations about the main symptom of three groups, such as the pectoralgia, reflux, heart rot and so on. Results: The efficacy of group A that was administrated with omeprazole and famotidine was obviously better than either of the omeprazole group or the famotidine group, and there was statistically significant difference (P〈0,05). Conclusion: The secretion of gastric acid can be effectively restrained which has reliable curative effect on reflux esophagitis. It is suggested that the secretion of stomach acid could be effectively restrained by omeprazole combined with famotidine. It is well worthy of promoting for the treatment of reflux esophagitis in the clinical field.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:13.58.73.22